Global Healthcare Currency Hedged ETF
Overview
Fund Objective
DRUG aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.
Benefits
Healthcare – a global growth opportunity
Ageing populations, rising living standards and ongoing medical advancements are expected to support increasing ongoing demand for healthcare products and services.
Simple access to global healthcare giants
Access a diversified portfolio of the world’s leading healthcare companies, such as Johnson & Johnson, Pfizer and Roche, in one trade.
Cost-effective
Passive, index-tracking approach means no ‘active manager’ fees, making DRUG a cost-effective investment for those seeking exposure to the global healthcare sector.
There are risks associated with an investment in DRUG, including market risk, international investment risk, healthcare sector risk and concentration risk. Investment value can go up and down. An investment in the Fund should only be considered as a part of a broader portfolio, taking into account your particular circumstances, including your tolerance for risk. For more information on risks and other features of the Fund, please see the Product Disclosure Statement and Target Market Determination, both available on this website.
Invest in DRUG with Betashares Direct
Key facts
Profile
| Units outstanding* (#) | 22,249,615 |
|---|---|
| Management fee and cost** (p.a.) | 0.57% |
| Distribution frequency | Semi-annual |
| Distribution reinvestment plan (DRP) | Full or partial participation available |
| Issuer | Betashares Capital Ltd |
| Registry | MUFG Corporate Markets |
| Domicile | Australia |
* As at 9 May 2025
**Certain additional costs apply. Please refer to PDS.
Pricing information
| Current price | |
|---|---|
| Last trade* | |
| % Change (prev day) | |
| Bid (delayed) | |
| Offer (delayed) | |
| * Data is delayed by at least 20 minutes. | |
| NAV | |
|---|---|
| NAV/Unit* | $7.55 |
| * As at 9 May 2025 | |
Past performance is not indicative of future performance. Please refer to "Fund returns after fees" for additional information regarding performance/return information.
Trading information
| ASX code | DRUG |
|---|---|
| Bloomberg code | DRUG AU |
| IRESS code | DRUG.AXW |
| iNAV IRESS code | N/A |
| Market makers | Susquehanna Pacific |
Index information
| Index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index |
|---|---|
| Index provider | Nasdaq |
| Index ticker | N/A |
| Bloomberg index ticker | NQXAUHHN Index |
Performance
Fund returns after fees (%)
| Fund | Index | |
|---|---|---|
| 1 month | -4.21% | -4.18% |
| 3 months | -5.43% | -5.40% |
| 6 months | -6.23% | -6.09% |
| 1 year | -2.71% | -2.30% |
| 3 year p.a. | 2.18% | 2.58% |
| 5 year p.a. | 6.08% | 6.51% |
| 10 year p.a. | - | 6.79% |
| Since inception p.a. | 7.04% | 7.39% |
| Inception date | 4-Aug-16 | - |
Past performance is not an indicator of future performance. Returns are calculated in Australian dollars using net asset value per unit at the start and end of the specified period and do not reflect brokerage or the bid ask spread that investors incur when buying and selling units on the ASX. Returns are after fund management costs, assume reinvestment of any distributions and do not take into account tax paid as an investor in the Fund. Returns for periods longer than one year are annualised. Current performance may be higher or lower than the performance shown.
Holdings and allocation
Portfolio holdings
| Name | Weight (%) |
|---|---|
| ELI LILLY & CO | 7.2 |
| JOHNSON & JOHNSON | 6.3 |
| UNITEDHEALTH GROUP INC | 6.2 |
| ABBVIE INC | 5.7 |
| NOVO NORDISK A/S | 4.0 |
| ABBOTT LABORATORIES | 3.9 |
| ASTRAZENECA PLC | 3.7 |
| ROCHE HOLDING AG | 3.7 |
| NOVARTIS AG | 3.6 |
| MERCK & CO INC | 3.4 |
Sector allocation
| Pharmaceuticals | 45.4% |
|---|---|
| Health Care Equipment | 17.2% |
| Biotechnology | 14.3% |
| Managed Health Care | 9.0% |
| Life Sciences Tools & Services | 7.2% |
| Health Care Supplies | 2.9% |
| Health Care Services | 1.6% |
| Health Care Facilities | 1.2% |
| Health Care Technology | 0.6% |
| Other | 0.5% |
* As of 30 April 2025
Country allocation
| United States | 79.9% |
|---|---|
| Switzerland | 5.4% |
| Japan | 3.9% |
| Denmark | 3.8% |
| Britain | 3.8% |
| France | 1.4% |
| Netherlands | 0.6% |
| China | 0.5% |
| Belgium | 0.3% |
| Other | 0.4% |
* As of 30 April 2025
Distributions
Frequency and yield
| Distribution frequency | Semi-Annual |
|---|---|
| 12 mth distribution yield* | 3.2% |
*As at 30 April 2025. Yield is calculated by summing the prior 12-month per unit distributions divided by the closing NAV per unit at the end of the relevant period. Yield will vary and may be lower at time of investment. Past performance is not indicative of future performance.
You can elect DRP by logging into MUFG’s Investor Centre. Once you are logged in, please proceed to the 'Payments and Tax' tab and select 'Reinvestment Plans'.
Recent distributions
| Ex Date | Record Date | Payment Date | Distribution Unit ($) | Annual Distribution Return (%) (1) |
|---|---|---|---|---|
| 2-Jan-25 | 3-Jan-25 | 17-Jan-25 | $0.027266 | 2.92% |
| 1-Jul-24 | 2-Jul-24 | 16-Jul-24 | $0.223016 | 3.24% |
| 2-Jan-24 | 3-Jan-24 | 17-Jan-24 | $0.026712 | 0.35% |
| 3-Jul-23 | 4-Jul-23 | 18-Jul-23 | - | 0.34% |
| 3-Jan-23 | 4-Jan-23 | 18-Jan-23 | $0.026198 | 0.33% |
| 1-Jul-22 | 4-Jul-22 | 18-Jul-22 | - | 0.24% |
| 4-Jan-22 | 5-Jan-22 | 19-Jan-22 | $0.019188 | 5.70% |
| 1-Jul-21 | 2-Jul-21 | 16-Jul-21 | $0.349841 | 5.55% |
| 4-Jan-21 | 5-Jan-21 | 19-Jan-21 | $0.016602 | 1.00% |
| 1-Jul-20 | 2-Jul-20 | 16-Jul-20 | $0.042923 | 1.13% |
| 2-Jan-20 | 3-Jan-20 | 17-Jan-20 | $0.024943 | 0.46% |
| 2-Jan-19 | 3-Jan-19 | 17-Jan-19 | $0.018694 | 4.03% |
| 2-Jul-18 | 3-Jul-18 | 17-Jul-18 | $0.184449 | 3.77% |
| 2-Jan-18 | 3-Jan-18 | 17-Jan-18 | $0.01646 | 0.35% |
1 This is the annual distribution return to the end of the relevant distribution date. The distribution return reflects the contribution to total investment return made by the Fund's distributions. Distribution return is calculated as the total return less the growth return. Total return is calculated as the percentage change in a continuing investor's interest in the Fund assuming reinvestment of all distributions back into the Fund (and no other application or withdrawal), net of ongoing fees. Growth return is the Fund's return excluding distributions, net of ongoing fees. Past performance is not indicative of future performance.